

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.52394560 |
| 2 | surfactant homeostasis (GO:0043129) | 4.21661023 |
| 3 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.99746723 |
| 4 | positive regulation of heat generation (GO:0031652) | 3.93085132 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 3.65468891 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 3.65468891 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.65468891 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.65468891 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.65468891 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.65468891 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 3.58008868 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 3.58008868 |
| 13 | tryptophan catabolic process (GO:0006569) | 3.58008868 |
| 14 | lymph vessel development (GO:0001945) | 3.54224323 |
| 15 | cardiac myofibril assembly (GO:0055003) | 3.53150297 |
| 16 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.48575781 |
| 17 | cellular response to ethanol (GO:0071361) | 3.48535862 |
| 18 | basement membrane organization (GO:0071711) | 3.48070292 |
| 19 | regulation of cholesterol storage (GO:0010885) | 3.41706042 |
| 20 | chemical homeostasis within a tissue (GO:0048875) | 3.38730386 |
| 21 | endothelium development (GO:0003158) | 3.38232215 |
| 22 | negative regulation of interleukin-12 production (GO:0032695) | 3.38166908 |
| 23 | apoptotic cell clearance (GO:0043277) | 3.35742608 |
| 24 | response to peptidoglycan (GO:0032494) | 3.31528898 |
| 25 | regulation of heat generation (GO:0031650) | 3.29540250 |
| 26 | neutrophil activation involved in immune response (GO:0002283) | 3.29290222 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.25251221 |
| 28 | myofibril assembly (GO:0030239) | 3.23213961 |
| 29 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12231679 |
| 30 | regulation of endothelial cell differentiation (GO:0045601) | 3.08520463 |
| 31 | kynurenine metabolic process (GO:0070189) | 3.07608960 |
| 32 | endothelial cell chemotaxis (GO:0035767) | 3.05960753 |
| 33 | regulation of fever generation (GO:0031620) | 3.05717087 |
| 34 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.04606009 |
| 35 | pinocytosis (GO:0006907) | 3.04289357 |
| 36 | fatty acid transmembrane transport (GO:1902001) | 2.98711880 |
| 37 | tryptophan metabolic process (GO:0006568) | 2.97989909 |
| 38 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97510176 |
| 39 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.96302224 |
| 40 | regulation of macrophage chemotaxis (GO:0010758) | 2.96178211 |
| 41 | macrophage activation involved in immune response (GO:0002281) | 2.93271529 |
| 42 | regulation of p38MAPK cascade (GO:1900744) | 2.92652646 |
| 43 | germinal center formation (GO:0002467) | 2.89699577 |
| 44 | low-density lipoprotein particle clearance (GO:0034383) | 2.87149475 |
| 45 | iron ion import (GO:0097286) | 2.86175404 |
| 46 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.85948659 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 2.84085574 |
| 48 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.83712892 |
| 49 | lymphangiogenesis (GO:0001946) | 2.82262631 |
| 50 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.81497117 |
| 51 | positive regulation of p38MAPK cascade (GO:1900745) | 2.80904805 |
| 52 | phospholipid homeostasis (GO:0055091) | 2.79635069 |
| 53 | glomerular visceral epithelial cell development (GO:0072015) | 2.77534555 |
| 54 | plasma membrane repair (GO:0001778) | 2.74804986 |
| 55 | protein localization to endosome (GO:0036010) | 2.74659509 |
| 56 | microglial cell activation (GO:0001774) | 2.72215460 |
| 57 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.71729867 |
| 58 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.69633166 |
| 59 | cellular response to exogenous dsRNA (GO:0071360) | 2.68680575 |
| 60 | regulation of mast cell activation (GO:0033003) | 2.67854512 |
| 61 | carnitine shuttle (GO:0006853) | 2.67374419 |
| 62 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.67296869 |
| 63 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.66181419 |
| 64 | sarcomere organization (GO:0045214) | 2.66041350 |
| 65 | regulation of sequestering of triglyceride (GO:0010889) | 2.64789876 |
| 66 | oligosaccharide catabolic process (GO:0009313) | 2.64466014 |
| 67 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.64170017 |
| 68 | negative regulation of lipid storage (GO:0010888) | 2.63842396 |
| 69 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.61943503 |
| 70 | cellular extravasation (GO:0045123) | 2.61496389 |
| 71 | substrate-dependent cell migration (GO:0006929) | 2.61153765 |
| 72 | blood vessel maturation (GO:0001955) | 2.61039254 |
| 73 | cell adhesion mediated by integrin (GO:0033627) | 2.58110424 |
| 74 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.57580978 |
| 75 | T-helper 1 type immune response (GO:0042088) | 2.57304008 |
| 76 | wound healing, spreading of epidermal cells (GO:0035313) | 2.57043065 |
| 77 | patterning of blood vessels (GO:0001569) | 2.55774140 |
| 78 | regulation of actin filament-based movement (GO:1903115) | 2.54450519 |
| 79 | regulation of mononuclear cell migration (GO:0071675) | 2.53748517 |
| 80 | granulocyte activation (GO:0036230) | 2.53615324 |
| 81 | glomerular basement membrane development (GO:0032836) | 2.53374486 |
| 82 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.53273413 |
| 83 | cardiac muscle hypertrophy (GO:0003300) | 2.52449058 |
| 84 | negative regulation of mast cell activation (GO:0033004) | 2.52448738 |
| 85 | NAD biosynthetic process (GO:0009435) | 2.51310841 |
| 86 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.50924280 |
| 87 | regulation of chronic inflammatory response (GO:0002676) | 2.50464888 |
| 88 | positive regulation of vasculogenesis (GO:2001214) | 2.49980441 |
| 89 | positive regulation of macrophage cytokine production (GO:0060907) | 2.49199063 |
| 90 | negative regulation of granulocyte differentiation (GO:0030853) | 2.48637367 |
| 91 | monocyte chemotaxis (GO:0002548) | 2.47854821 |
| 92 | endothelial cell morphogenesis (GO:0001886) | 2.46593682 |
| 93 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.45316565 |
| 94 | response to fluid shear stress (GO:0034405) | 2.45309027 |
| 95 | blood vessel endothelial cell migration (GO:0043534) | 2.45242106 |
| 96 | positive regulation of mast cell activation (GO:0033005) | 2.45176495 |
| 97 | morphogenesis of an endothelium (GO:0003159) | 2.44654198 |
| 98 | endothelial tube morphogenesis (GO:0061154) | 2.44654198 |
| 99 | eosinophil chemotaxis (GO:0048245) | 2.44635948 |
| 100 | coronary vasculature morphogenesis (GO:0060977) | 2.43424396 |
| 101 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.43060325 |
| 102 | muscle hypertrophy (GO:0014896) | 2.41464590 |
| 103 | neutrophil activation (GO:0042119) | 2.41003832 |
| 104 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.40628139 |
| 105 | amino-acid betaine transport (GO:0015838) | 2.40600003 |
| 106 | carnitine transport (GO:0015879) | 2.40600003 |
| 107 | glomerular epithelial cell development (GO:0072310) | 2.40359019 |
| 108 | striated muscle hypertrophy (GO:0014897) | 2.38714188 |
| 109 | negative regulation of interleukin-8 production (GO:0032717) | 2.38216678 |
| 110 | positive regulation of natural killer cell activation (GO:0032816) | 2.37503366 |
| 111 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.36702920 |
| 112 | axon extension involved in axon guidance (GO:0048846) | 2.36702920 |
| 113 | intracellular lipid transport (GO:0032365) | 2.36510840 |
| 114 | positive regulation of interferon-alpha production (GO:0032727) | 2.36232273 |
| 115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.36104204 |
| 116 | lysine catabolic process (GO:0006554) | 2.36059671 |
| 117 | lysine metabolic process (GO:0006553) | 2.36059671 |
| 118 | nerve growth factor signaling pathway (GO:0038180) | 2.35434270 |
| 119 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.35329711 |
| 120 | positive regulation of mast cell degranulation (GO:0043306) | 2.35329711 |
| 121 | regulation of sarcomere organization (GO:0060297) | 2.35295967 |
| 122 | ovulation from ovarian follicle (GO:0001542) | 2.34961388 |
| 123 | heart trabecula formation (GO:0060347) | 2.34948156 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.34268515 |
| 125 | response to host immune response (GO:0052572) | 2.34268515 |
| 126 | detection of molecule of bacterial origin (GO:0032490) | 2.33469071 |
| 127 | positive regulation of acute inflammatory response (GO:0002675) | 2.33245008 |
| 128 | regulation of vasculogenesis (GO:2001212) | 2.33046587 |
| 129 | regulation of gamma-delta T cell activation (GO:0046643) | 2.32876295 |
| 130 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.32752040 |
| 131 | amine catabolic process (GO:0009310) | 2.32729143 |
| 132 | cellular biogenic amine catabolic process (GO:0042402) | 2.32729143 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.32617511 |
| 134 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.31731054 |
| 135 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.30889383 |
| 136 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.30119590 |
| 137 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.28877222 |
| 138 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.28784732 |
| 139 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.28537444 |
| 140 | response to thyroid hormone (GO:0097066) | 2.28473439 |
| 141 | carnitine transmembrane transport (GO:1902603) | 2.28138150 |
| 142 | actin-myosin filament sliding (GO:0033275) | 2.27236689 |
| 143 | muscle filament sliding (GO:0030049) | 2.27236689 |
| 144 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.27166625 |
| 145 | lipoprotein transport (GO:0042953) | 2.26990621 |
| 146 | regulation of platelet activation (GO:0010543) | 2.26858032 |
| 147 | positive regulation of developmental pigmentation (GO:0048087) | 2.26324436 |
| 148 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.26253397 |
| 149 | 2-oxoglutarate metabolic process (GO:0006103) | 2.25114355 |
| 150 | relaxation of cardiac muscle (GO:0055119) | 2.25023192 |
| 151 | eosinophil migration (GO:0072677) | 2.24981895 |
| 152 | positive regulation of lipid storage (GO:0010884) | 2.24878100 |
| 153 | neutrophil mediated immunity (GO:0002446) | 2.24672548 |
| 154 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.24436039 |
| 155 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.24322637 |
| 156 | positive regulation of interleukin-6 production (GO:0032755) | 2.24015272 |
| 157 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.23485568 |
| 158 | glomerular filtration (GO:0003094) | 2.23395768 |
| 159 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.23307482 |
| 160 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.22756613 |
| 161 | muscle hypertrophy in response to stress (GO:0003299) | 2.22756613 |
| 162 | cardiac muscle adaptation (GO:0014887) | 2.22756613 |
| 163 | complement activation, alternative pathway (GO:0006957) | 2.21538844 |
| 164 | ceramide catabolic process (GO:0046514) | 2.21358400 |
| 165 | regulation of chemokine biosynthetic process (GO:0045073) | 2.21052876 |
| 166 | protein K11-linked deubiquitination (GO:0035871) | 2.21050021 |
| 167 | macrophage activation (GO:0042116) | 2.21027296 |
| 168 | transcytosis (GO:0045056) | 2.20740414 |
| 169 | fibroblast migration (GO:0010761) | 2.20693731 |
| 170 | regulation of integrin activation (GO:0033623) | 2.20666467 |
| 171 | regulation of skeletal muscle contraction (GO:0014819) | 2.20356340 |
| 172 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.20224981 |
| 173 | signal peptide processing (GO:0006465) | 2.19714119 |
| 174 | regulation of mast cell degranulation (GO:0043304) | 2.17151395 |
| 175 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.17125757 |
| 176 | regulation of interleukin-12 production (GO:0032655) | 2.16948963 |
| 177 | positive regulation of defense response to virus by host (GO:0002230) | 2.14334374 |
| 178 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.13996789 |
| 179 | glycosphingolipid catabolic process (GO:0046479) | 2.13929251 |
| 180 | negative regulation of cytokine secretion (GO:0050710) | 2.13784646 |
| 181 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.13566057 |
| 182 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.12169200 |
| 183 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.11662432 |
| 184 | positive regulation of interleukin-17 production (GO:0032740) | 2.11339434 |
| 185 | JAK-STAT cascade (GO:0007259) | 2.08994982 |
| 186 | regulation of growth of symbiont in host (GO:0044126) | 2.08278280 |
| 187 | negative regulation of growth of symbiont in host (GO:0044130) | 2.08278280 |
| 188 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.08278280 |
| 189 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.08278280 |
| 190 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.08161941 |
| 191 | response to ATP (GO:0033198) | 2.07830049 |
| 192 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.07436140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.05188014 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58698473 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.92285606 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.70673958 |
| 5 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.48822991 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.42186023 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.41733740 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41310011 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.40006598 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37191299 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32797769 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28758245 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.28004560 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27248543 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.20742325 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.19120384 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.18032354 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16080890 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15475664 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.06145426 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01037454 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98239592 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.97795456 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96951648 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.96641374 |
| 26 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.91632096 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85475105 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80338453 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.78401193 |
| 30 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.77444096 |
| 31 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.74656723 |
| 32 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.74656723 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73983601 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73038044 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72156665 |
| 36 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70355807 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69152025 |
| 38 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.68732016 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.67554524 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61945212 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61327902 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61287171 |
| 43 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.61043452 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.60999364 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56117946 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53912751 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.53593760 |
| 48 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.52880026 |
| 49 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52541461 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52296226 |
| 51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50807305 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48019281 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47108785 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46208600 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.45488000 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41491592 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.40989544 |
| 58 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.39795528 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34813242 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34801158 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.34763451 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34478841 |
| 63 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33598172 |
| 64 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33587818 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32419511 |
| 66 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32157079 |
| 67 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31966295 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30874670 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30286418 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.30039862 |
| 71 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29276574 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28521017 |
| 73 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27319369 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27033244 |
| 75 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.25746915 |
| 76 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25211225 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.24934515 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24300494 |
| 79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.24003433 |
| 80 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22694877 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22523606 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22377273 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20998040 |
| 84 | CJUN_26792858_Chip-Seq_BT549_Human | 1.19922802 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18922998 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18626487 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18510779 |
| 88 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16161309 |
| 89 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.15725277 |
| 90 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15039003 |
| 91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15004146 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14272015 |
| 93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14151439 |
| 94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13545668 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.12859035 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12859035 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 1.11925567 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11898999 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11429747 |
| 100 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11344675 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10742381 |
| 102 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10534100 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10073507 |
| 104 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09887590 |
| 105 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08990579 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08902271 |
| 107 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08510603 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08095372 |
| 109 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06847991 |
| 110 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06260508 |
| 111 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06108828 |
| 112 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06108828 |
| 113 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06108828 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05982420 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.05954771 |
| 116 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.05190260 |
| 117 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04832009 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03633204 |
| 119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03137366 |
| 120 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02922397 |
| 121 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.02657086 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02620606 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02620606 |
| 124 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01574109 |
| 125 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01031273 |
| 126 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00812641 |
| 127 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99584777 |
| 128 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.98857155 |
| 129 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98520325 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98113615 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97617033 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97547056 |
| 133 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97473226 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97026528 |
| 135 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97026528 |
| 136 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96657371 |
| 137 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96207683 |
| 138 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95934735 |
| 139 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95736422 |
| 140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95308598 |
| 141 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94531685 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94461143 |
| 143 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93067986 |
| 144 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92924050 |
| 145 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92874965 |
| 146 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.92868172 |
| 147 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92367241 |
| 148 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92176438 |
| 149 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92021316 |
| 150 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90668509 |
| 151 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90491125 |
| 152 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90449666 |
| 153 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90433791 |
| 154 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90248154 |
| 155 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86578620 |
| 156 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83618411 |
| 157 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80929982 |
| 158 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.80757315 |
| 159 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79194696 |
| 160 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.79182288 |
| 161 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77380076 |
| 162 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77187327 |
| 163 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76672424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 3.66561833 |
| 2 | MP0003191_abnormal_cellular_cholesterol | 3.40522765 |
| 3 | MP0005167_abnormal_blood-brain_barrier | 3.27212411 |
| 4 | MP0003195_calcinosis | 3.04526156 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.03044875 |
| 6 | MP0004272_abnormal_basement_membrane | 3.02787549 |
| 7 | MP0001879_abnormal_lymphatic_vessel | 2.89007278 |
| 8 | MP0003828_pulmonary_edema | 2.82939937 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.49714251 |
| 10 | MP0009785_altered_susceptibility_to | 2.39944326 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.29438366 |
| 12 | MP0003724_increased_susceptibility_to | 2.16297492 |
| 13 | MP0005670_abnormal_white_adipose | 2.13920381 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.13304911 |
| 15 | MP0000751_myopathy | 2.10289987 |
| 16 | MP0004130_abnormal_muscle_cell | 2.08960761 |
| 17 | MP0008438_abnormal_cutaneous_collagen | 2.07128582 |
| 18 | MP0004036_abnormal_muscle_relaxation | 2.06282880 |
| 19 | MP0000343_altered_response_to | 2.04607508 |
| 20 | MP0002139_abnormal_hepatobiliary_system | 1.97375137 |
| 21 | MP0004510_myositis | 1.96205606 |
| 22 | MP0003566_abnormal_cell_adhesion | 1.93567088 |
| 23 | MP0005360_urolithiasis | 1.92001185 |
| 24 | MP0002332_abnormal_exercise_endurance | 1.91562460 |
| 25 | MP0000749_muscle_degeneration | 1.86344462 |
| 26 | MP0003303_peritoneal_inflammation | 1.82033473 |
| 27 | MP0005671_abnormal_response_to | 1.80376099 |
| 28 | MP0000767_abnormal_smooth_muscle | 1.78900113 |
| 29 | MP0003279_aneurysm | 1.78257107 |
| 30 | MP0006138_congestive_heart_failure | 1.78193827 |
| 31 | MP0004215_abnormal_myocardial_fiber | 1.74616862 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.73644164 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.73528735 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.73528735 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.73516785 |
| 36 | MP0009840_abnormal_foam_cell | 1.73134830 |
| 37 | MP0001790_abnormal_immune_system | 1.72900762 |
| 38 | MP0005387_immune_system_phenotype | 1.72900762 |
| 39 | MP0005330_cardiomyopathy | 1.69369665 |
| 40 | MP0010630_abnormal_cardiac_muscle | 1.69306289 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.69035241 |
| 42 | MP0005385_cardiovascular_system_phenoty | 1.68812675 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.68812675 |
| 44 | MP0001958_emphysema | 1.68592158 |
| 45 | MP0008775_abnormal_heart_ventricle | 1.66186724 |
| 46 | MP0005025_abnormal_response_to | 1.63783460 |
| 47 | MP0009278_abnormal_bone_marrow | 1.62094966 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.58807949 |
| 49 | MP0004484_altered_response_of | 1.55538068 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 1.55238760 |
| 51 | MP0005451_abnormal_body_composition | 1.54026761 |
| 52 | MP0005165_increased_susceptibility_to | 1.52510821 |
| 53 | MP0002723_abnormal_immune_serum | 1.50524720 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.48060211 |
| 55 | MP0004087_abnormal_muscle_fiber | 1.46344235 |
| 56 | MP0003690_abnormal_glial_cell | 1.45760116 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.41955848 |
| 58 | MP0003075_altered_response_to | 1.40560238 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.38278617 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.37185514 |
| 61 | MP0001800_abnormal_humoral_immune | 1.36659188 |
| 62 | MP0005620_abnormal_muscle_contractility | 1.34338823 |
| 63 | MP0005647_abnormal_sex_gland | 1.31508453 |
| 64 | MP0001835_abnormal_antigen_presentation | 1.30662399 |
| 65 | MP0005310_abnormal_salivary_gland | 1.30337270 |
| 66 | MP0003646_muscle_fatigue | 1.27616892 |
| 67 | MP0000249_abnormal_blood_vessel | 1.25350121 |
| 68 | MP0003436_decreased_susceptibility_to | 1.24398417 |
| 69 | MP0004185_abnormal_adipocyte_glucose | 1.24285295 |
| 70 | MP0002419_abnormal_innate_immunity | 1.23387623 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.22706168 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.22007995 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.20262516 |
| 74 | MP0004043_abnormal_pH_regulation | 1.17709825 |
| 75 | MP0002405_respiratory_system_inflammati | 1.15735105 |
| 76 | MP0002128_abnormal_blood_circulation | 1.14368943 |
| 77 | MP0000569_abnormal_digit_pigmentation | 1.12857555 |
| 78 | MP0002127_abnormal_cardiovascular_syste | 1.12335640 |
| 79 | MP0001819_abnormal_immune_cell | 1.12095117 |
| 80 | MP0002420_abnormal_adaptive_immunity | 1.11732425 |
| 81 | MP0006082_CNS_inflammation | 1.09712792 |
| 82 | MP0010329_abnormal_lipoprotein_level | 1.07004034 |
| 83 | MP0000230_abnormal_systemic_arterial | 1.06252704 |
| 84 | MP0001756_abnormal_urination | 1.03825273 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.03517067 |
| 86 | MP0002136_abnormal_kidney_physiology | 1.03299433 |
| 87 | MP0002998_abnormal_bone_remodeling | 1.02608047 |
| 88 | MP0005332_abnormal_amino_acid | 1.00184940 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.99614348 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.99520757 |
| 91 | MP0004147_increased_porphyrin_level | 0.98069784 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.97440342 |
| 93 | MP0005164_abnormal_response_to | 0.96874861 |
| 94 | MP0000685_abnormal_immune_system | 0.96758393 |
| 95 | MP0004947_skin_inflammation | 0.96359451 |
| 96 | MP0005535_abnormal_body_temperature | 0.96081117 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.95543129 |
| 98 | MP0005266_abnormal_metabolism | 0.95105839 |
| 99 | MP0008004_abnormal_stomach_pH | 0.94704977 |
| 100 | MP0003091_abnormal_cell_migration | 0.94700479 |
| 101 | MP0002106_abnormal_muscle_physiology | 0.94448801 |
| 102 | MP0005171_absent_coat_pigmentation | 0.93660165 |
| 103 | MP0001614_abnormal_blood_vessel | 0.93559316 |
| 104 | MP0001915_intracranial_hemorrhage | 0.92842066 |
| 105 | MP0004085_abnormal_heartbeat | 0.92773653 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92425076 |
| 107 | MP0000604_amyloidosis | 0.90644029 |
| 108 | MP0003045_fibrosis | 0.89673831 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.89455884 |
| 110 | MP0000266_abnormal_heart_morphology | 0.88749482 |
| 111 | MP0002925_abnormal_cardiovascular_devel | 0.87557581 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.86309137 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.86004039 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.85148154 |
| 115 | MP0009780_abnormal_chondrocyte_physiolo | 0.84792012 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.84528570 |
| 117 | MP0004883_abnormal_blood_vessel | 0.84499589 |
| 118 | MP0003252_abnormal_bile_duct | 0.83722441 |
| 119 | MP0004145_abnormal_muscle_electrophysio | 0.83718693 |
| 120 | MP0009115_abnormal_fat_cell | 0.83575540 |
| 121 | MP0001764_abnormal_homeostasis | 0.83536843 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.81827801 |
| 123 | MP0002269_muscular_atrophy | 0.81360394 |
| 124 | MP0005253_abnormal_eye_physiology | 0.80493238 |
| 125 | MP0008469_abnormal_protein_level | 0.80311760 |
| 126 | MP0005166_decreased_susceptibility_to | 0.80204440 |
| 127 | MP0002254_reproductive_system_inflammat | 0.80181556 |
| 128 | MP0005275_abnormal_skin_tensile | 0.80096122 |
| 129 | MP0003633_abnormal_nervous_system | 0.79740742 |
| 130 | MP0009764_decreased_sensitivity_to | 0.79713101 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.79562343 |
| 132 | MP0001853_heart_inflammation | 0.79272859 |
| 133 | MP0004019_abnormal_vitamin_homeostasis | 0.78102389 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.77342348 |
| 135 | MP0006054_spinal_hemorrhage | 0.76738813 |
| 136 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75705528 |
| 137 | MP0005410_abnormal_fertilization | 0.74368488 |
| 138 | MP0008057_abnormal_DNA_replication | 0.74148670 |
| 139 | MP0002933_joint_inflammation | 0.72966121 |
| 140 | MP0005369_muscle_phenotype | 0.72514451 |
| 141 | MP0009763_increased_sensitivity_to | 0.71957216 |
| 142 | MP0000689_abnormal_spleen_morphology | 0.71914412 |
| 143 | MP0005334_abnormal_fat_pad | 0.71755556 |
| 144 | MP0000716_abnormal_immune_system | 0.71708789 |
| 145 | MP0005376_homeostasis/metabolism_phenot | 0.71200560 |
| 146 | MP0005551_abnormal_eye_electrophysiolog | 0.68775295 |
| 147 | MP0001986_abnormal_taste_sensitivity | 0.68163424 |
| 148 | MP0000920_abnormal_myelination | 0.66472623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.15468802 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.87631277 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.87631277 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.87631277 |
| 5 | Hematochezia (HP:0002573) | 4.50794026 |
| 6 | Spontaneous hematomas (HP:0007420) | 4.23729687 |
| 7 | Glomerulonephritis (HP:0000099) | 4.04765811 |
| 8 | Stomatitis (HP:0010280) | 3.96215916 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 3.83243229 |
| 10 | Ventricular tachycardia (HP:0004756) | 3.82579332 |
| 11 | Complement deficiency (HP:0004431) | 3.73278070 |
| 12 | Sudden death (HP:0001699) | 3.72174678 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.61353236 |
| 14 | Optic neuritis (HP:0100653) | 3.61353236 |
| 15 | Asymmetric septal hypertrophy (HP:0001670) | 3.56497391 |
| 16 | Cerebral aneurysm (HP:0004944) | 3.52926826 |
| 17 | Polycythemia (HP:0001901) | 3.42268695 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.38997760 |
| 19 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.32886624 |
| 20 | Increased connective tissue (HP:0009025) | 3.32583801 |
| 21 | Nephritis (HP:0000123) | 3.30986654 |
| 22 | Axonal loss (HP:0003447) | 3.29195647 |
| 23 | Muscle fiber splitting (HP:0003555) | 3.28306106 |
| 24 | Orchitis (HP:0100796) | 3.26433956 |
| 25 | Myositis (HP:0100614) | 3.15302042 |
| 26 | Abnormality of complement system (HP:0005339) | 3.13627952 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.03997893 |
| 28 | Esophageal varix (HP:0002040) | 2.99691111 |
| 29 | Lymphangioma (HP:0100764) | 2.90009179 |
| 30 | Keratoconjunctivitis (HP:0001096) | 2.81308649 |
| 31 | Atrial fibrillation (HP:0005110) | 2.77228819 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.74785765 |
| 33 | Hyperactive renin-angiotensin system (HP:0000841) | 2.73491968 |
| 34 | Hyporeflexia of lower limbs (HP:0002600) | 2.72002649 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 2.69649509 |
| 36 | Lipoatrophy (HP:0100578) | 2.68717629 |
| 37 | Exercise-induced myalgia (HP:0003738) | 2.66116306 |
| 38 | Right ventricular cardiomyopathy (HP:0011663) | 2.65747809 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.65304666 |
| 40 | Hypokalemic alkalosis (HP:0001949) | 2.62563385 |
| 41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.62301252 |
| 42 | Subaortic stenosis (HP:0001682) | 2.62301252 |
| 43 | Dysostosis multiplex (HP:0000943) | 2.61994957 |
| 44 | Abnormality of the periventricular white matter (HP:0002518) | 2.61802760 |
| 45 | Broad metatarsal (HP:0001783) | 2.61241434 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.60097160 |
| 47 | Congenital stationary night blindness (HP:0007642) | 2.56135238 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.54754240 |
| 49 | Calf muscle hypertrophy (HP:0008981) | 2.52872669 |
| 50 | Clumsiness (HP:0002312) | 2.52228092 |
| 51 | Eczematoid dermatitis (HP:0000976) | 2.51398311 |
| 52 | Primary atrial arrhythmia (HP:0001692) | 2.49782300 |
| 53 | Hemoptysis (HP:0002105) | 2.49021299 |
| 54 | Supraventricular arrhythmia (HP:0005115) | 2.45047212 |
| 55 | Hyperventilation (HP:0002883) | 2.40810948 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39434462 |
| 57 | Prolonged bleeding time (HP:0003010) | 2.39297284 |
| 58 | Difficulty running (HP:0009046) | 2.36324418 |
| 59 | Abnormality of chloride homeostasis (HP:0011422) | 2.36042920 |
| 60 | Visceral angiomatosis (HP:0100761) | 2.35744496 |
| 61 | Abnormality of the calf musculature (HP:0001430) | 2.33703911 |
| 62 | Bone cyst (HP:0012062) | 2.33570587 |
| 63 | Thick nail (HP:0001805) | 2.32246117 |
| 64 | Supraventricular tachycardia (HP:0004755) | 2.32183808 |
| 65 | Myoglobinuria (HP:0002913) | 2.31956462 |
| 66 | Increased circulating renin level (HP:0000848) | 2.30370878 |
| 67 | Abnormal drinking behavior (HP:0030082) | 2.30351686 |
| 68 | Polydipsia (HP:0001959) | 2.30351686 |
| 69 | Metabolic alkalosis (HP:0200114) | 2.30075496 |
| 70 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.26577754 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.22401385 |
| 72 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21801005 |
| 73 | Loss of speech (HP:0002371) | 2.21795292 |
| 74 | Hemangiomatosis (HP:0007461) | 2.21779318 |
| 75 | Distal lower limb muscle weakness (HP:0009053) | 2.19486405 |
| 76 | EMG: myopathic abnormalities (HP:0003458) | 2.17148800 |
| 77 | Episodic fever (HP:0001954) | 2.16548244 |
| 78 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15499879 |
| 79 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.14711506 |
| 80 | Conjunctival telangiectasia (HP:0000524) | 2.14408162 |
| 81 | Prostate neoplasm (HP:0100787) | 2.14058824 |
| 82 | Congenital sensorineural hearing impairment (HP:0008527) | 2.11000892 |
| 83 | Polyneuropathy (HP:0001271) | 2.10140836 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.09665904 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09665904 |
| 86 | Joint hemorrhage (HP:0005261) | 2.09642951 |
| 87 | Mediastinal lymphadenopathy (HP:0100721) | 2.09341588 |
| 88 | Albinism (HP:0001022) | 2.09174896 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.08886436 |
| 90 | Aneurysm (HP:0002617) | 2.08861860 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 2.08784060 |
| 92 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08653040 |
| 93 | Vertigo (HP:0002321) | 2.08360786 |
| 94 | Disinhibition (HP:0000734) | 2.07753742 |
| 95 | Dilated cardiomyopathy (HP:0001644) | 2.06597267 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 2.06420214 |
| 97 | Deep venous thrombosis (HP:0002625) | 2.05642307 |
| 98 | Arterial thrombosis (HP:0004420) | 2.05467784 |
| 99 | Cerebral hemorrhage (HP:0001342) | 2.04728814 |
| 100 | Myocardial infarction (HP:0001658) | 2.01352949 |
| 101 | Pulmonary artery stenosis (HP:0004415) | 2.00996864 |
| 102 | Increased CSF protein (HP:0002922) | 2.00815467 |
| 103 | Portal hypertension (HP:0001409) | 2.00136710 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99195513 |
| 105 | Hemorrhage of the eye (HP:0011885) | 1.98770999 |
| 106 | Pancreatic cysts (HP:0001737) | 1.98194769 |
| 107 | Aortic aneurysm (HP:0004942) | 1.98148594 |
| 108 | Leukocytosis (HP:0001974) | 1.97989434 |
| 109 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97824603 |
| 110 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97824603 |
| 111 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97824603 |
| 112 | Hypoglycemic coma (HP:0001325) | 1.97119490 |
| 113 | Protruding tongue (HP:0010808) | 1.96557021 |
| 114 | Gout (HP:0001997) | 1.95988712 |
| 115 | Pulmonary embolism (HP:0002204) | 1.95667183 |
| 116 | Fair hair (HP:0002286) | 1.95217603 |
| 117 | Mucosal telangiectasiae (HP:0100579) | 1.93716922 |
| 118 | Urethral obstruction (HP:0000796) | 1.93677232 |
| 119 | Facial diplegia (HP:0001349) | 1.93646251 |
| 120 | Absent speech (HP:0001344) | 1.92387656 |
| 121 | Hyperaldosteronism (HP:0000859) | 1.91526564 |
| 122 | Epistaxis (HP:0000421) | 1.90864446 |
| 123 | Tubular atrophy (HP:0000092) | 1.90837077 |
| 124 | Syncope (HP:0001279) | 1.89891979 |
| 125 | Abnormality of binocular vision (HP:0011514) | 1.89705099 |
| 126 | Diplopia (HP:0000651) | 1.89705099 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.89051815 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.89031166 |
| 129 | Hypoalphalipoproteinemia (HP:0003233) | 1.88520051 |
| 130 | Hyperglycinuria (HP:0003108) | 1.87847850 |
| 131 | Abnormality of the renal cortex (HP:0011035) | 1.86117869 |
| 132 | Hypoplastic ischia (HP:0003175) | 1.86080898 |
| 133 | Abnormality of the hepatic vasculature (HP:0006707) | 1.85983838 |
| 134 | Abnormal urine output (HP:0012590) | 1.85808422 |
| 135 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85549159 |
| 136 | Increased serum ferritin (HP:0003281) | 1.84752080 |
| 137 | Polyuria (HP:0000103) | 1.84664382 |
| 138 | Ketoacidosis (HP:0001993) | 1.84455132 |
| 139 | Mutism (HP:0002300) | 1.84306192 |
| 140 | Mesangial abnormality (HP:0001966) | 1.84241357 |
| 141 | Stomach cancer (HP:0012126) | 1.84235705 |
| 142 | Petechiae (HP:0000967) | 1.84105144 |
| 143 | Bundle branch block (HP:0011710) | 1.84083195 |
| 144 | Abnormality of renin-angiotensin system (HP:0000847) | 1.83629410 |
| 145 | Abnormality of purine metabolism (HP:0004352) | 1.83226930 |
| 146 | Chondrocalcinosis (HP:0000934) | 1.82404745 |
| 147 | Progressive visual loss (HP:0000529) | 1.82172564 |
| 148 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.81996323 |
| 149 | Abnormality of proline metabolism (HP:0010907) | 1.81952612 |
| 150 | Hydroxyprolinuria (HP:0003080) | 1.81952612 |
| 151 | Cavernous hemangioma (HP:0001048) | 1.81648196 |
| 152 | Decreased circulating renin level (HP:0003351) | 1.80929469 |
| 153 | Nuclear cataract (HP:0100018) | 1.80289306 |
| 154 | Testicular atrophy (HP:0000029) | 1.80044040 |
| 155 | Generalized muscle weakness (HP:0003324) | 1.80032708 |
| 156 | Tubulointerstitial fibrosis (HP:0005576) | 1.79720201 |
| 157 | Recurrent fungal infections (HP:0002841) | 1.78114827 |
| 158 | Prolonged QT interval (HP:0001657) | 1.77502756 |
| 159 | Tetany (HP:0001281) | 1.75851415 |
| 160 | Hypercholesterolemia (HP:0003124) | 1.75744805 |
| 161 | Abnormality of the ischium (HP:0003174) | 1.75219056 |
| 162 | Paralysis (HP:0003470) | 1.75168301 |
| 163 | Gaze-evoked nystagmus (HP:0000640) | 1.73670442 |
| 164 | Vasculitis (HP:0002633) | 1.70805187 |
| 165 | Widely spaced teeth (HP:0000687) | 1.70638912 |
| 166 | Abnormality of the pleura (HP:0002103) | 1.69649016 |
| 167 | Abnormality of the prostate (HP:0008775) | 1.69618447 |
| 168 | Adactyly (HP:0009776) | 1.67724049 |
| 169 | Global brain atrophy (HP:0002283) | 1.67603230 |
| 170 | Frequent falls (HP:0002359) | 1.67361754 |
| 171 | Recurrent skin infections (HP:0001581) | 1.66927174 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.01738871 |
| 2 | TGFBR2 | 5.16319885 |
| 3 | TIE1 | 5.08219944 |
| 4 | KDR | 3.75512709 |
| 5 | TTN | 2.97595993 |
| 6 | ADRBK2 | 2.41637302 |
| 7 | RIPK1 | 2.37345453 |
| 8 | ACVR1B | 2.34931536 |
| 9 | TRIB3 | 2.30969990 |
| 10 | ERN1 | 2.16956151 |
| 11 | CAMK1D | 2.11990521 |
| 12 | BMPR2 | 2.02471802 |
| 13 | GRK7 | 1.99862349 |
| 14 | WNK4 | 1.94216510 |
| 15 | PKN2 | 1.86370965 |
| 16 | DMPK | 1.84787646 |
| 17 | IRAK1 | 1.82000426 |
| 18 | TXK | 1.80553601 |
| 19 | MAP2K3 | 1.76888314 |
| 20 | BLK | 1.75345126 |
| 21 | TYK2 | 1.67847450 |
| 22 | MYLK | 1.64763356 |
| 23 | TEC | 1.62134420 |
| 24 | MAP4K2 | 1.57219182 |
| 25 | CAMK1G | 1.56817320 |
| 26 | PIK3CG | 1.52092480 |
| 27 | IKBKB | 1.45451472 |
| 28 | OBSCN | 1.39662636 |
| 29 | STK10 | 1.38323912 |
| 30 | BMPR1B | 1.35137571 |
| 31 | PTK6 | 1.32990597 |
| 32 | EPHB1 | 1.30239713 |
| 33 | PTK2B | 1.30082082 |
| 34 | TGFBR1 | 1.27884568 |
| 35 | KIT | 1.21184268 |
| 36 | MAPK12 | 1.19694456 |
| 37 | PDGFRA | 1.19059478 |
| 38 | INSRR | 1.18003077 |
| 39 | MAP3K14 | 1.17442409 |
| 40 | EPHA3 | 1.16156081 |
| 41 | WNK3 | 1.11963585 |
| 42 | PAK4 | 1.10278746 |
| 43 | JAK1 | 1.09832999 |
| 44 | MAPKAPK3 | 1.08360251 |
| 45 | CSK | 1.06629500 |
| 46 | NEK9 | 1.05298074 |
| 47 | TBK1 | 1.04268622 |
| 48 | IKBKE | 1.00840596 |
| 49 | FES | 1.00065148 |
| 50 | DAPK2 | 0.99544309 |
| 51 | PINK1 | 0.99193645 |
| 52 | MAP3K3 | 0.98786466 |
| 53 | JAK2 | 0.91815420 |
| 54 | MST1R | 0.90803633 |
| 55 | SYK | 0.90262732 |
| 56 | CAMK4 | 0.88582482 |
| 57 | IRAK3 | 0.88230641 |
| 58 | PDK2 | 0.88204229 |
| 59 | PRKAA2 | 0.84641855 |
| 60 | BCKDK | 0.83199479 |
| 61 | IRAK4 | 0.83138314 |
| 62 | PHKG2 | 0.82363842 |
| 63 | PHKG1 | 0.82363842 |
| 64 | OXSR1 | 0.82182560 |
| 65 | MAP3K7 | 0.81724352 |
| 66 | DDR2 | 0.81107140 |
| 67 | MAP2K6 | 0.80845274 |
| 68 | FGFR4 | 0.80662460 |
| 69 | FGR | 0.80281899 |
| 70 | CSF1R | 0.79591858 |
| 71 | PRKD1 | 0.79208388 |
| 72 | MAPK13 | 0.78980748 |
| 73 | PKN1 | 0.78564095 |
| 74 | SIK1 | 0.76473464 |
| 75 | CDC42BPA | 0.73834830 |
| 76 | PIK3CA | 0.72859332 |
| 77 | SGK3 | 0.72308562 |
| 78 | LYN | 0.71594875 |
| 79 | LMTK2 | 0.70310111 |
| 80 | NTRK3 | 0.69737851 |
| 81 | EPHB2 | 0.69124373 |
| 82 | WNK1 | 0.67726580 |
| 83 | CAMKK2 | 0.65728676 |
| 84 | LCK | 0.64721137 |
| 85 | BTK | 0.64688809 |
| 86 | MATK | 0.64264532 |
| 87 | BMX | 0.64058391 |
| 88 | LRRK2 | 0.64023555 |
| 89 | MAPK7 | 0.63463659 |
| 90 | GRK1 | 0.63354166 |
| 91 | CHUK | 0.62650249 |
| 92 | TAOK2 | 0.62298233 |
| 93 | ADRBK1 | 0.60124743 |
| 94 | PDPK1 | 0.59336156 |
| 95 | MAP3K10 | 0.58802716 |
| 96 | HCK | 0.57944377 |
| 97 | ITK | 0.57251323 |
| 98 | IRAK2 | 0.56239432 |
| 99 | JAK3 | 0.55970923 |
| 100 | EGFR | 0.55812176 |
| 101 | TSSK6 | 0.55429752 |
| 102 | PRKCH | 0.55305720 |
| 103 | MARK3 | 0.55150394 |
| 104 | CDK12 | 0.54696911 |
| 105 | PDK3 | 0.54230132 |
| 106 | PDK4 | 0.54230132 |
| 107 | MET | 0.53546248 |
| 108 | MAPKAPK5 | 0.53376326 |
| 109 | FGFR3 | 0.53358648 |
| 110 | PDK1 | 0.51310744 |
| 111 | MAP3K6 | 0.49700547 |
| 112 | ZAP70 | 0.49245004 |
| 113 | TNK2 | 0.48781389 |
| 114 | ERBB3 | 0.47556799 |
| 115 | IGF1R | 0.47325736 |
| 116 | SGK2 | 0.46862526 |
| 117 | GSK3A | 0.46815650 |
| 118 | FER | 0.46576396 |
| 119 | STK24 | 0.46479699 |
| 120 | PRKCE | 0.46063317 |
| 121 | PDGFRB | 0.45805756 |
| 122 | RIPK4 | 0.45492276 |
| 123 | STK38 | 0.45304281 |
| 124 | CLK1 | 0.44994965 |
| 125 | GRK5 | 0.44114352 |
| 126 | NLK | 0.44063252 |
| 127 | MAP3K4 | 0.43649318 |
| 128 | SCYL2 | 0.43459412 |
| 129 | MAP4K1 | 0.42828928 |
| 130 | PRKCQ | 0.42788541 |
| 131 | PTK2 | 0.41773671 |
| 132 | AKT3 | 0.41591092 |
| 133 | PRKG2 | 0.40871983 |
| 134 | MAP3K13 | 0.40010452 |
| 135 | MAP2K4 | 0.39365713 |
| 136 | ABL1 | 0.39225308 |
| 137 | MAP3K1 | 0.38124920 |
| 138 | TRPM7 | 0.37270831 |
| 139 | MOS | 0.37209637 |
| 140 | ICK | 0.37074812 |
| 141 | LATS1 | 0.36771569 |
| 142 | MAPK4 | 0.36177259 |
| 143 | MAP3K11 | 0.35829256 |
| 144 | CDK6 | 0.35530117 |
| 145 | TAOK3 | 0.35336217 |
| 146 | STK3 | 0.35265384 |
| 147 | TAOK1 | 0.34963112 |
| 148 | MAP2K1 | 0.32387951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.26034101 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.29606170 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18404373 |
| 4 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.09757365 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.07426167 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.07169239 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.06812624 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.04675356 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 1.97827897 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95381429 |
| 11 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.92020247 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.84973054 |
| 13 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.81658232 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81578300 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.76474307 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.74324867 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.73540673 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.61473147 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61291161 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59629621 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.56199563 |
| 22 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53092496 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48038743 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.44624770 |
| 25 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.42477339 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41261238 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39968729 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.39164394 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.34832351 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33654644 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.33645347 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.32252031 |
| 33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.27974731 |
| 34 | Adherens junction_Homo sapiens_hsa04520 | 1.25825864 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24830479 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.22412217 |
| 37 | Lysine degradation_Homo sapiens_hsa00310 | 1.20220094 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19330845 |
| 39 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18113030 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15819444 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.13287395 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.11692313 |
| 43 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.11463865 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.08674555 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08524664 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06807647 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 1.05568712 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04037703 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03638045 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.02918821 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 0.99818552 |
| 52 | Platelet activation_Homo sapiens_hsa04611 | 0.95550465 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95100571 |
| 54 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94223436 |
| 55 | Measles_Homo sapiens_hsa05162 | 0.93198225 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.92751346 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 0.91740376 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88839464 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.87612808 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85628252 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84878180 |
| 62 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84848517 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.84439520 |
| 64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83716062 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82495454 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.82429419 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.82268045 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.80146143 |
| 69 | Phagosome_Homo sapiens_hsa04145 | 0.79889478 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78764008 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.78658748 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78598922 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78383502 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.78170462 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77480655 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.76190551 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.75419315 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.75365509 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75071595 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75045937 |
| 81 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74904466 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74886571 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74855508 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72625574 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70117570 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.69025011 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.68897665 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66445939 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.64879016 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.64865628 |
| 91 | Mineral absorption_Homo sapiens_hsa04978 | 0.64292467 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63893991 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.63316893 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.62366260 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62075948 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.62011042 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61979381 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.61753937 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60189600 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59661495 |
| 101 | Morphine addiction_Homo sapiens_hsa05032 | 0.59587717 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59416496 |
| 103 | Salivary secretion_Homo sapiens_hsa04970 | 0.59291616 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.55993101 |
| 105 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55909159 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55400155 |
| 107 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54802531 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54147505 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53906822 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.53378707 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52585818 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.51796423 |
| 113 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51657422 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.48139403 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47785693 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47473886 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47336140 |
| 118 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46792346 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.45601865 |
| 120 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45327099 |
| 121 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45069551 |
| 122 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44908725 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44759716 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44286179 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44066857 |
| 126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.43881285 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43856764 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43701080 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42402837 |
| 130 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42074013 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41349166 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41318441 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41095172 |
| 134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.40978685 |
| 135 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40320310 |
| 136 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39834766 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39540936 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38233787 |
| 139 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38215351 |
| 140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38131230 |
| 141 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37729697 |
| 142 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37446169 |
| 143 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36649815 |
| 144 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36537251 |
| 145 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36459099 |
| 146 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36200684 |
| 147 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36066513 |
| 148 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35980747 |
| 149 | Hepatitis B_Homo sapiens_hsa05161 | 0.34193886 |
| 150 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33829045 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33717269 |

